Patent · US Active

Systems and methods for transvenous lead implantation

US8000810B2 · kind B2 · utility

0Cited by

29References

9Claims

0Family size

Assignee

Cardiac Pacemakers, Inc. · US

Inventors

G. Shantanu Reddy · Minneapolis, US
Shrojalkumar Desai · Little Canada, US

Key dates

Filing date	Mar 20, 2007
Grant date	Aug 16, 2011
Priority date	—
Expiry date	May 20, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61N1/057
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Some embodiments relate to a method of implanting a cardiac lead. An expansion module is implanted in a target region within vasculature, the target region being defined by a portion of a brachiocephalic vein and a portion of a corresponding subclavian vein. The expansion module is transitioned from a collapsed state to an expanded state within the target region to contact the vasculature. A cardiac lead is implanted through the expansion module, the cardiac lead defining an intermediate section corresponding to the target region. The intermediate section of the cardiac lead includes a surface treatment adapted to reduce at least one of cell proliferation, thrombosis, fibrosis, and inflammation at the target region.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.